<DOC>
	<DOCNO>NCT01800708</DOCNO>
	<brief_summary>The aim present study investigate outcome congenital cataract surgery inject intraoperative intracameral triamcinolone versus postoperative use oral prednisolone . This prospective , randomized clinical trial . Sixty child submit congenital cataract surgery young 2 year age . They randomly divide two group . The study group receive intraoperative intracameral triamcinolone acetonide injection . The control group receive prednisolone syrup postoperatively . The surgical outcome assess one year .</brief_summary>
	<brief_title>Cataract Surgery With Intracameral Triamcinolone Infants</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Patients young 2 year age Unilateral bilateral congenital cataract compromise red reflex Corneal opacity Glaucoma Aniridia Subluxated cataract Traumatic cataract Complex microphthalmia Persistant hyperplastic primary vitreous Retinal detachment Patients intraoperative complication , IOL implant sulcus</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>